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ABSTRACT 
 
Background and Objectives: Incidence of hospital-acquired diarrhea has increased rapidly and burn patients are at high risk 
of getting it. Infection with C. difficile is the most common cause of antibiotic associated diarrhea. The aim of this study was 
to determine the baseline characteristics and clinical presentation of hospital-acquired diarrhea and compare C. difficile and 
non-C. difficile diarrhea in burn patients treated at a burn center.
Materials and Methods: During a 1-year study all patients with hospital-acquired diarrhea at Motahari Burn Hospital, Teh-
ran, Iran enrolled in this study. We compared patients with a stool sample positive for C. difficile toxin or tracing the antigen 
in patients who were negative for detection of toxin in their stool sample specimens.
Results: Diarrhea developed in 37 patients out of 3200 admitted patients with a mean burn size of 34.8 ±20.1%. Among 
them, 8 patients had a positive result for C. difficile. The mean time between antibiotic therapy and occurrence of diarrhea 
was 9.5 ± 6.2 days. Nine (23.7%) patients died in the 7.8± 4.2 days, mostly due to co-morbidities. The mean duration of di-
arrhea was 3.6 ± 2 days. Twenty two (57.9%) patients were treated with oral metronidazol and eleven (28.9%) patients were 
treated with combination of metronidazole and vancomycin, higher rate of combination therapy was seen in Clostridium 
difficile CDI.
Conclusion: Overall, the prevalence of hospital-acquired diarrhea was 120/10,000  and 21% of them caused by infection 
with C. difficile. Presence of peripheral leukocytosis and colitis were the alarm sign for diagnosis of C. difficile infection.   
Keywords: Hospital-acquired diarrhea (HAD), Burn, Clostridium difficile infection (CDI)        
and 2–32% of admitted patients in general medicine 
wards (2). There are many causes of HAD, includ-
ing medications, nasogastric tube feeding, bowel 
ischemia, or constipation causing pseudodiarrhea 
(3, 4). Other risk factors are age, length of hospital-
ization, nutritional status, immune status, and expo-
sure to gastrointestinal procedures such as nasogas-
tric intubation and endoscopy (2). Prolonged use of 
broad spectrum antibiotics, which disrupt normal 
colonic flora followed by colonization of Clostridium 
difficile, is the most common cause of HAD. Patients 
may acquire pathogens during contact with other 
patients, healthcare workers, or contaminated hospi-
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INTRODUCTION
Incidence of hospital-acquired diarrhea (HAD) 
has increased rapidly. Overall rates of HAD range 
from 2.3 to 4.1 illnesses per 100 admissions on pe-
diatric wards and from 7.7 per 100 admissions to 
41% of adults hospitalized in intensive care units (1) 
http://ijm.tums.ac.ir
tal surface (1, 2). Crowded hospital wards, increased 
use of broad-spectrum antibiotics, and relative-
ly poor infection control, stomach acid–inhibiting 
agents such as proton-pump inhibitors and histamine 
type 2 antagonists, prior hospitalization, severity of 
underlying illness, fuoroquinolones, older than 65 
years have been associated with increased risk for 
CDI (3, 5, 6).
Burn patients are at high risk for infectious 
complication such as HAD due to alterations in their 
skin and mucosal barriers, general altered physiolo-
gy in response to the stress of injury, and increased 
incidence of established risk factors of HAD (5). Be-
sides HAD may cause additional medical complica-
tions for severely ill patients and pose an increased 
risk of mortality (2). Considering that the early diag-
nosis of HAD and urgent appropriate treatment are 
clinically crucial, the aim of this study was to deter-
mine the baseline characteristics and clinical presen-
tation of HAD and compare C. difficile and non-C. 
difficile diarrhea in burn patients treated at a burn 
center.
 
METHODS
 
   During a 1-year prospective cross-sectional study 
(1/Jun/2013-1/Jun/2014), all patients with HAD (at 
least 1 day with ≥3 watery or unformed stools occur-
ring ≥ 48 hours after hospital admission) in Motahari 
Burn Hospital, Tehran, Iran enrolled in this study. 
We compared patients with a stool sample positive 
for C. difficile toxin (A or B) or antigen by an im-
munoassay enzyme with patients with HAD diarrhea 
with a stool sample negative for C. difficile. Patients 
who were hospitalized with diarrhea were excluded. 
Demographic characteristics, clinical presentation, 
and duration of disease were analyzed, along with 
baseline laboratory analyses including leukocyte and 
platelet count, and stool exam. Treatment regimens 
included oral metronidazole and in refractory cases 
combination of oral metrondazole and vancomycin. 
The study was approved by the ethical committee of 
the hospital.
Results are expressed as frequencies and percent-
ages for categorical variables and compare with 
chi-square test, and as means for continuous vari-
ables and compare with the independent sample 
t-test. P-values < 0.05 were considered significant. 
Statistical analysis was performed using SPSS 
version 21.
 
RESULTS
Diarrhea developed in 37 patients out of 3200 
admitted patients (120/10,000) with a mean burn 
size of 34.8 ±20.1%. Among them, 7 patients had a 
positive result for C.difficile toxin and antigen and 1 
patient had only for toxin (21%). Demographic data 
are presented in Table 1. The patients’ mean age was 
38.6 ±14.8 (range, 18-75) years. A total of 26 (68.4%) 
patients were male, while all of the patients had 
surgical intervention (e.g.; fasciotomy, scarotomy). 
All patients had been previously treated with antibi-
otics in hospital settings. Three (7.9%) patients had 
diabetes, while none had gastrointestinal diseases. 
The mean time between antibiotic therapy and oc-
currence of diarrhea was 9.5 ± 6.2 days (range, 1-30), 
(10.8 ± 4.9 d in CDI versus 9.2 ± 6.6 d in HAD P= 
0.5).
Fever, and abdominal cramps occurred in 23 
(62.2%), and 10 (27%) patients, respectively. Only 
four patients (11.1%) had RBC in their stool exams, 
and fourteen patients (37.8%) had WBC in their stool 
exams; it was higher among patients with CDI than 
among patients suffering diarrhea without CDI (75% 
versus 27.6%, P=0.02).  Nine (23.7%) patients died in 
the 7.8± 4.2 days, mostly due to co-morbidities (one 
patient died due to diarrhea). The mean duration of 
diarrhea was 3.6 ± 2 (1–8) days (4 ± 2.1 d in CDI 
versus 3.5 ± 2 d in HAD, P= 0.5).
Laboratory analyses, including WBC counts, he-
moglobin, platelet count, albumin, blood sugar, and 
calcium are presented in Table 2. Twenty two (57.9%) 
patients were treated with oral metronidazol and 
eleven (28.9%) patients were treated with combina-
tion of metronidazole and vancomycin, higher rate 
of combination therapy was seen in CDI than HAD 
(P= 0.05).
There were no differences in patient age, gender, 
burn size, burn degree, or season. There were also 
no differences between the groups in temperature, 
abdominal cramp, albumin, hemoglobin, or platelet 
levels. The only significant findings that differed be-
tween the two types of diarrhea was the white blood 
cell count on the day of diagnosis (16928.5 ± 8328.8 
versus 1190 ± 4976.7, P= 0.02) and the presence of 
leukocyte in stool exam (P= 0.02).
IRAN. J. MICROBIOL.  Volume 7 Number 6 (December 2015) 310-314            311 http://ijm.tums.ac.ir
HOSPITAL ACQUIRED DIARRHEA 
http://ijm.tums.ac.ir
 
DISCUSSION
   HAD is a recognized cause of increased morbid-
ity, mortality, hospital length of stay, and healthcare 
costs. Diarrhea also affects patient outcomes by limit-
ing the use of necessary treatments such as antibiotics, 
enteral nutrition, immunosuppressants, and antineo-
plastics.  Broad-spectrum antibiotics and antibiotics 
that achieve high concentrations within the intestinal 
lumen posed the greatest risk of antibiotic-associat-
ed diarrhea because they disrupt the intestinal flora 
to a greater degree. In such cases, antibiotic removal 
of bacteria that normally produce butyrate, a colon-
ic epithelial cell nutrient, and break down undigested 
carbohydrates results in epithelial dysfunction and an 
increased osmotic load within the intestinal lumen, 
leading to diarrhea ( 4). HAD has many causes but C. 
difficile infection (CDI) is the most common cause of 
antibiotic associated diarrhea (1, 7). 
   This study design focuses on the differences between 
patients with CDI and non-CDI hospital diarrhea in a 
clinical setting. The incidence of HAD in our setting 
Table 1. Demographic data of patients with HAD
Gender: Male
                 Female
Age ( mean ± SD) y
Season: Spring
                 Summer
           Fall
             winter
Burn size ( mean ± SD)  
Burn type: Electrical
                        Gas explosion
         Fire
                Gasoline
           Scald
             others 
Fever (%)
Abdominal cramp (%)
Death (%)
CDI 
6 (75%)
2 (25%)
33.5 ± 9.2
0
5 (62.5%)
2 (25%)
1 (12.5%)
29.8 ± 20.4
2
2
2
1
0
1
7 (87.5)
2 (25)
1 (12.5)
HAD
20 (66.7%)
10 (33.3%)
40 ± 15.8
7 (23.3%)
12 (40%)
1 (3.3%)
10 (33.3%)
36.1 ± 20.1
8
8
3
3
4
3
16 (55.2)
8 (27.6)
8 (26.7)
Total 
26 (68.4%)
12 (31.6%)
38.6 ± 14.8
7 (18.4%)
17 (44.7%)
3 (7.9%)
11 (28.9%)
34.8 ±20.1
10
10
5
4
4
4
23 (62.2)
10 (27)
9 (23.7)
P. Value
0.5
0.2
0.06
0.4
0.8
0.1
0.6
0.3
CDI: C.Difficile Infection, HAD: Hospital-Acquired Diarrhea
Table 2. laboratory Data of patients with HAD
WBC ( mean ± SD) 103cell/µL
Hg ( mean ± SD) g/dl
Platelet ( mean ± SD) 103/ µL
Albumin ( mean ± SD) g/dL
Blood Sugar ( mean ± SD)mg/dL
Calcium ( mean ± SD)mg/dL
Stool Exam: WBC (%)
                     RBC (%)
CDI
16.9 ± 8.3
10.9 ± 1.4
292.2 ± 55.8
2.61 ± 0.4
106.1 ± 20.3
6.9 ± 0.7
6 (75)
1 (14.5)
HAD
11.1 ± 4.9
10.8 ±1.1
310.4 ± 144.5
2.8 ± 0.4
103.9 ± 32.5
7.1 ± 1.1
8 (27.6)
3 (10.3)
Total
12.2 ± 6
10.8 ± 1.2
306.9 ± 131.9
2.7 ± 0.4
104.3 ± 30.3
7.1 ± 1
14 (37.8)
4 (11.1)
P. Value
0.02
0.7
0.7
0.3
0.8
0.5
0.02
0.7
CDI: C.Difficile Infection, HAD: Hospital-Acquired Diarrhea
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was 12/1000 and 21% of them were CDI. The calcu-
lated incidence of HAD was from 2 to 41% in differ-
ent investigation according to different study design 
and environment (1, 4, 5, 8). Acquisition of diarrhea 
occurred within 1-30 days of antibiotic exposure and 
75% of them in the first 14 days, similarly as other 
surveys (2, 6, 9). According to preexisting severe burn 
condition of our patients, all of them had received an-
tibiotic and underwent surgical procedure. 
   CDI usually causes watery diarrhea, sometimes with 
mucus (suggestive colitis), while bloody diarrhea is 
exceptional (6, 10). Similarly, we found only 14.5% 
bloody diarrhea however colitis was found in 75% 
of our patients that was more in CDI prevalent than 
HAD.  
    Fever, abdominal cramping, and peripheral leuko-
cytosis are common in CDI (6, 10) but only peripheral 
leukocytosis was more prevalent in our study. 
   The laboratory analyses among our patients showed 
hypoalbominemia similar to other study (6). Low al-
bumin level is a consequence of malabsorption that 
can be seen in diarrhea. 
   The mean duration of diarrhea in our patients was 
3.6 days. It was shorter than other study like Korac 
and et al. (7.10 ± 4.88 d) (6). The burn patients are 
very critical patients and diarrhea adds to problems in 
patient care, disturbs fluid and electrolyte balance, and 
worsens nutritional status, so it should be diagnosed 
and treated promptly and aggressively as had be done 
in our setting.
    Lv et al. observed no significant difference in demo-
graphics, age and gender, duration of hospitalization, 
clinical outcomes, albumin or WBC counts between 
two groups (CDI and HAD) (11), the same as our 
study except for peripheral leukocytosis that was seen 
in our CDI group.    
    The CDI mortality rate reported in a number of stud-
ies varies from 13%–27% ( 12, 13). Similarly, in our 
study the case-fatality rate for patients with CDI was 
12.5% as compared to 26.7% for patients with HAD, 
and there was no significant difference. However, Za-
har et al. found that ICU- and hospital crude mortality 
of CDI were 21 and 34%, respectively (14). Variabil-
ity of the patient populations was their explanation of 
this difference. 
   In conclusion, we found no significant difference in 
demographics, age and gender, duration of diarrhea, 
clinical outcome, albumin, hemoglubin or platelet 
count between 2 groups. The only significant findings 
that differed between the two types of diarrhea was the 
white blood cell count on the day of diagnosis and the 
presence of leukocyte in stool exam. So patients with 
HAD, leukocytosis and colitis should be evaluated for 
CDI and prompt treatment of it.  
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